Combination Therapies Boosting Cognitive Function: Vitamin D and Neuroprotective Agents Combination therapies with vitamin D and other neuroprotective agents show promise for treating neurological diseases with inflammatory and neurodegenerative components
Genetic variants related to phase I and phase II detoxification of xenobiotic compounds are linked to multiple chemical sensitivity
Studies show that insufficient B12 impacts hormone production
Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms
BPC-157 applied locally at the injury site improved ligament healing across functional, biomechanical, macroscopic, and histological measures over 90 days
Given that cuproptosis preferentially targets OXPHOS-dependent cells by disrupting TCA cycle enzymes and Fe-S cluster integrity, 167,213 it remains an open question whether GSH-dependent Fe-S cluster biogenesis similarly licenses susceptibility to cuproptosis